Mpox Resource Center

In light of the recent cases of mpox in the U.S., the National Coalition for LGBTQ Health has curated a library of evidence-based materials in multiple formats about mpox. Geared to clinicians, researchers, and community members, the resources provide information about mpox virus transmission, prevention, testing, and treatment.

Resources from CDC

Scientists at the Centers for Disease Control and Prevention (CDC) are tracking multiple cases of monkeypox that have been reported in several countries that don’t normally report mpox, including the United States.

It’s not clear how the people were exposed to mpox, but early data suggest that gay, bisexual, and other men who have sex with men make up a high number of cases. However, anyone who has been in close contact with someone who has mpox is at risk. CDC is urging healthcare providers in the U.S. to be alert for patients who have rash illnesses consistent with mpox, regardless of whether they have travel or specific risk factors for mypox and regardless of gender or sexual orientation.

CDC is working with state and local health officials to identify people who may have been in contact with individuals who have tested positive for mpox, so they can monitor their health.

New and Updated

Evidence-based interventions are needed to respond to current and future mpox outbreaks within and beyond the United States. To help meet domestic and international mpox response goals, CDC is urging clinicians to let patients with mpox know that oral tecovirimat is available through STOMP and encourage them to enroll. Providers should inform patients about STOMP so they can consider enrolling in the study. However, enrollment in the study is voluntary, and patients who decline to take part, or who do not meet the criteria to participate, can still obtain tecovirimat if recommended. For more information about obtaining TPOXX or about the STOMP study, visit www.cdc.gov/poxvirus/mpox/clinicians/obtaining-tecovirimat.html or https://www.stomptpoxx.org/main.

Potential Risk for New Mpox Cases: CDC Health Alert Network
In the United States, cases of mpox (formerly monkeypox) have declined since peaking in August 2022, but the outbreak is not over. The CDC continues to receive reports of cases that reflect ongoing community transmission in the United States and internationally.

Updated Information for Healthcare Providers: Tecovirimat (TPOXX) and Guidance for Tecovirimat Use pages are now live.

CDC released a new MMWR highlighting shortfalls in progress toward equitable mpox vaccination coverage. Notably, as of April 2023, two thirds of mpox vaccine-eligible persons remain unvaccinated, and the shortfall was greatest among Black and AI/AN persons.

Mpox Resource Center

Resources from CDC

New and Updated

Advisory Committee on Immunization Practices (ACIP) Meeting, Feb. 22-24, 2023

If You Are Sick

Funding Resources

Community

Health Departments

VIDEOS

Data and Analytics

Additional CDC Resources

Partner ReSources

Copyright © 2023 National Coalition for LGBTQ Health | All rights reserved.